Christopher T. Letson
Impact in
-
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Acute Myeloid Leukemia Research 6
-
- Single-cell and spatial transcriptomics 2
- Cancer-related gene regulation 2
- Signaling Pathways in Disease 1
- Protein Degradation and Inhibitors 1
- Co-authors
- Eric Padron (7 shared papers)Maria E. Balasis (6 shared papers)Aref Al‐Kali (1 shared paper)Rami S. Komrokji (5 shared papers)David A. Sallman (2 shared papers)Abhishek A. Mangaonkar (1 shared paper)Ayalew Tefferi (1 shared paper)Traci Kruer (4 shared papers)
- Journals
- Blood (4 papers)Pharmacological Research (1 paper)Leukemia (1 paper)Blood Cancer Journal (1 paper)Comparative Medicine (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Christopher T. Letson
10 papers receiving 75 citations
Peers
Comparison fields: 5 of 36
- Hematology 35
- Genetics 25
- Endocrinology 6
- Molecular Biology 34
- Dermatology 4
Countries citing papers authored by Christopher T. Letson
This map shows the geographic impact of Christopher T. Letson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher T. Letson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher T. Letson more than expected).
Fields of papers citing papers by Christopher T. Letson
This network shows the impact of papers produced by Christopher T. Letson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher T. Letson. The network helps show where Christopher T. Letson may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher T. Letson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 31 | |
| 2 | 2019 | 11 | |
| 3 | 2019 | 10 | |
| 4 | 2022 | 9 | |
| 5 | 2013 | 8 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2017 | 1 | |
| 9 | 2022 | 1 | |
| 10 | 2019 | 1 |
About Christopher T. Letson
Christopher T. Letson is a scholar working on Hematology, Molecular Biology, Genetics, Immunology and Oncology, having authored 10 papers that have together received 75 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Single-cell and spatial transcriptomics (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cancer-related gene regulation (2 papers), Signaling Pathways in Disease (1 paper), Protein Degradation and Inhibitors (1 paper) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Hematology (35 citations), Genetics (25 citations), Endocrinology (6 citations), Molecular Biology (34 citations) and Dermatology (4 citations). Christopher T. Letson has collaborated with scholars based in United States and Germany. Frequent co-authors include Eric Padron, Maria E. Balasis, Aref Al‐Kali, Rami S. Komrokji, David A. Sallman, Abhishek A. Mangaonkar, Ayalew Tefferi, Traci Kruer, Mrinal M. Patnaik and Alexis Vedder. Their work appears in journals such as Blood, Pharmacological Research, Leukemia, Blood Cancer Journal and Comparative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.